Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination
Open Access
- 5 June 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (6) , e0178622
Abstract
The cuprizone animal model, also known as the toxic demyelination model, is a well-reproducible model of demyelination- and remyelination in mice, and has been useful in studying important aspect of human demyelinating diseases, including multiple sclerosis. In this study, we investigated the role of acid sphingomyelinase in demyelination and myelin repair by inducing acute and chronic demyelination with 5- or 12-week cuprizone treatment, followed by a 2-week cuprizone withdrawal phase to allow myelin repair. Sphingolipids, in particular ceramide and the enzyme acid sphingomyelinase, which generates ceramide from sphingomyelin, seem to be involved in astrocyte activation and neuronal damage in multiple sclerosis. We used immunohistochemistry to study glial reaction and oligodendrocyte distribution in acid sphingomyelinase deficient mice and wild-type C57BL/6J littermates at various time intervals after demyelination and remyelination. Axonal injury was quantified using amyloid precursor protein and synaptophysin, and gene expression and protein levels were measured using gene analysis and Western blotting, respectively. Our results show that mice lacking acid sphingomyelinase had a significant increase in myelin recovery and a significantly higher oligodendrocyte cell count after 2 weeks remyelination compared to wild-type littermates. Detrimental astroglial distribution was also significantly reduced in acid sphingomyelinase deficient animals. We obtained similar results in experiments using amitriptyline to inhibit acid sphingomyelinase. These findings suggest that acid sphingomyelinase plays a significant role in myelin repair, and its inhibition by amitriptyline may constitute a novel therapeutic approach for multiple sclerosis patients.Keywords
This publication has 29 references indexed in Scilit:
- Disease-specific molecular events in cortical multiple sclerosis lesionsBrain, 2013
- Fibroblast Growth Factor Receptor Signaling in Oligodendrocytes Regulates Myelin Sheath ThicknessThe Journal of Neuroscience, 2012
- Identification of Novel Functional Inhibitors of Acid SphingomyelinasePLOS ONE, 2011
- Aberrant Upregulation of Astroglial Ceramide Potentiates Oligodendrocyte InjuryBrain Pathology, 2011
- Astrocytes from the Contused Spinal Cord Inhibit Oligodendrocyte Differentiation of Adult Oligodendrocyte Precursor Cells by Increasing the Expression of Bone Morphogenetic ProteinsJournal of Neuroscience, 2011
- Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): A Novel Pharmacological Group of Drugs with Broad Clinical ApplicationsCellular Physiology and Biochemistry, 2010
- Diagnosis of inflammatory demyelination in biopsy specimens: a practical approachActa Neuropathologica, 2008
- Responses of reactive astrocytes containing S100β protein and fibroblast growth factor‐2 in the border and in the adjacent preserved tissue after a contusion injury of the spinal cord in rats: implications for wound repair and neuroregenerationWound Repair and Regeneration, 2007
- Acid and neutral sphingomyelinases: roles and mechanisms of regulationBiochemistry and Cell Biology, 2004
- CD95 Signaling via Ceramide-rich Membrane RaftsJournal of Biological Chemistry, 2001